Goserelin depot in the treatment of premenopausal advanced breast cancer
- 1 April 1992
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (4-5) , 810-814
- https://doi.org/10.1016/0959-8049(92)90120-q
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group.Journal of Clinical Oncology, 1989
- Luteinizing Hormone-Releasing Hormone Agonists in the Treatment of Breast CancerPublished by Springer Nature ,1988
- A Reappraisal of Oophorectomy in Carcinoma of the BreastAnnals of Surgery, 1987
- A randomized comparison of tamoxifen with surgical oophorectomy in premenopausal patients with advanced breast cancer.Journal of Clinical Oncology, 1986
- The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancerBritish Journal of Cancer, 1986
- Randomized trial of bilateral oophorectomy versus tamoxifen in premenopausal women with metastatic breast cancer.Journal of Clinical Oncology, 1986
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977
- PROPHYLACTIC VERSUS THERAPEUTIC CASTRATION IN THE TOTAL TREATMENT OF BREAST CANCERObstetrical & Gynecological Survey, 1962
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896